1. Effect of Recombinant Human Erythropoietin on Quality of Life in Cancer Patients Receiving Chemotherapy 
Gregoris Iconomou, PhD, Angelos Koutras, MD, Antonis Rigopoulos, MD, Apostolos G Vagenakis, MD, Haralabos P Kalofonos, MD, PhD 
Journal of Pain and Symptom Management 
Volume 25, Issue 6, Pages (June 2003)
DOI: /S (03)

2. Fig. 1
Comparison of QOL mean change scores by treatment group: independent sample t-tests. The range of CLAS instruments is 0–100 and of FACT-Fatigue is 0–52.
Journal of Pain and Symptom Management  , DOI: ( /S (03) )